| 000 | 01660 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514023920.0 | ||
| 264 | 0 | _c20020611 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.46.3.689-694.2002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNavon-Venezia, Shiri | |
| 245 | 0 | 0 |
_aAntibacterial properties of dermaseptin S4 derivatives with in vivo activity. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMar 2002 |
||
| 300 |
_a689-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAmphibian Proteins |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xpharmacology |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemolysis _xdrug effects |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNeutropenia _xblood |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aFeder, Rina | |
| 700 | 1 | _aGaidukov, Leonid | |
| 700 | 1 | _aCarmeli, Yehuda | |
| 700 | 1 | _aMor, Amram | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 46 _gno. 3 _gp. 689-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.46.3.689-694.2002 _zAvailable from publisher's website |
| 999 |
_c11758712 _d11758712 |
||